depression

News

Novi Sad, Serbia - October 6, 2014: Woman's hands Googling on electronic device.Woman hands holding and touching on Apple iPad mini with Google search web page on a screen.

Otsuka, Click trial digital depression therapy with Google

Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully remote clinical trial testing a digital therapy as an add-on in adults

News

Novartis buys neurology biotech Cadent for up to $770m

Novartis is to buy neuroscience drugs firm Cadent Therapeutics in a deal worth up to $770 million.

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

VC fund dedicated to psychedelic meds launches in UK

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow.

News

Biogen bulks up pipeline with Sage drugs in $3bn deal

With the prospects for its Alzheimer’s drug aducanumab still up in the air, Biogen has moved to shore up its late-stage pipeline with a $3 billion licensing deal with Sage that adds drugs f

News

MindMed aims for Nasdaq listing after Compass' magic mushroo...

Compass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy firm Mind Medicine is aiming to follow suit by up-listing its shares on

News

Compass plans $100m IPO to fund magic mushroom depression dr...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic m

Otsuka, Click trial digital depression therapy with Google

Novartis buys neurology biotech Cadent for up to $770m

VC fund dedicated to psychedelic meds launches in UK

Biogen bulks up pipeline with Sage drugs in $3bn deal

MindMed aims for Nasdaq listing after Compass' magic mushroo...

Compass plans $100m IPO to fund magic mushroom depression dr...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

depression

Editor's Picks